Cruz-Jentoft Alfonso J., Morley John E. (eds.) Sarcopenia

2nd edition. — Wiley-Blackwell, 2021. — 447 p. — ISBN: 978-1-119-59787-2.Sarcopenia is common in older men and women, and yet awareness of its clinical relevance is still relatively low. Only formally included in the International Classification of Diseases in 2016, the condition may impact societies with serious health-related and financial consequences unless consistent, effective methods of identification and management are adopted. This second edition of Sarcopenia provides geriatricians and other healthcare professionals with a revised and expanded examination of this understudied and underdiagnosed condition. Edited by two leading authorities on the subject, it covers the epidemiology and diagnosis of sarcopenia, as well as treatment options and possible prevention strategies. Eight newly written chapters build upon existing knowledge with fresh data on topics including sarcopenia’s biomarkers and its impact on the healthcare economy. Containing vital information for clinicians and other professionals working in geriatric care, nursing homes, nutrition, cancer, endocrinology, surgery, sports medicine, and many other specialties, Sarcopenia, second edition, is a groundbreaking and essential new resource.Definitions of Sarcopenia.
Epidemiology of Muscle Mass Loss with Age.
The Role of Mitochondria in Age‐Related Sarcopenia.
Motor Unit Remodeling.
Nutrition, Protein Turnover, and Muscle Mass.
Recognizing Persons at Risk for Sarcopenia.
Adverse Outcomes and Functional Consequences of Sarcopenia.
A Lifecourse Approach to Sarcopenia.
Acute Sarcopenia.
Sarcopenia, Frailty, and Intrinsic Capacity.
Osteosarcopenia.
Sarcopenic Obesity.
Sarcopenia and Cognitive Impairment.
Sarcopenia and Other Chronic Organ Diseases.
Imaging of Skeletal Muscle.
Measurements of Muscle Mass, Equations, and Cut‐off Points 199.
Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans: Methods, Early Results, and Future Directions.
Measurement of Muscle Strength and Power.
Measurements of Physical Performance.
Biomarkers for Physical Frailty and Sarcopenia: A “Two‐Body Problem”.
Quality of Life and Sarcopenia.
Exercise Interventions to Prevent and Improve Sarcopenia.
Nutritional Approaches to Treat Sarcopenia.
Beta‐hydroxy‐beta‐methylbutyrate (HMB) and Sarcopenia.
The Future of Drug Treatments.
Sarcopenia: Is It Preventable?
Financial Impact of Sarcopenia.
Sarcopenia Management for Clinicians.